Papagiannis Dimitrios, Tiganis Nikolaos, Kotsiou Ourania S, Lampropoulos Ioannis C, Fradelos Evangelos C, Malli Foteini, Gourgoulianis Konstantinos I
Public Health & Adults Immunization Laboratory, School of Health Sciences, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece.
Primary Health Care Postgraduate Program, University of Thessaly, 41500 Larissa, Greece.
Healthcare (Basel). 2024 Aug 2;12(15):1536. doi: 10.3390/healthcare12151536.
The introduction of a new vaccine into immunization programs represents a significant advancement in the global effort to combat vaccine-preventable diseases. Data from the World Health Organization support that immunization prevents between 2 and 3 million deaths each year across various diseases, underscoring its pivotal role in global health. The present study aims to assess the knowledge, attitudes, and anticipated vaccination practices among health professionals in Central Greece in response to the potential introduction of new Respiratory Syncytial Virus (RSV) vaccination guidelines by the National Vaccines Committee. Among the 450 health professionals solicited for the study, 219 provided responses, yielding a response rate of approximately 55%. A substantial majority (70.3%) accurately identified the vaccine's current availability, and 62.1% were aware of the current recommendation for RSV vaccination in pregnant women. In response to whether health professionals support the inclusion of an RSV vaccine in the national vaccination program if it becomes commercially available and is recommended by the Greek National Immunization Program, general practitioners showed the most support, with an average score of 4.86 (95% CI, 4.69-5.00), followed by pediatricians at 4.76 (95% CI, 4.63-4.89), pulmonologists at 4.68 (95% CI, 4.36-5.00), and obstetricians at 4.33 (95% CI, 3.95-4.71). Concerning general opinions on vaccinations, a high level of agreement was noted among the majority of health professionals, excluding nurses. Pharmacists recorded the highest agreement, with a perfect score of 5 (CI, 5.00-5.00), followed closely by pediatricians at 4.99 (CI, 4.97-5.00), GPs at 4.95 (CI, 4.85-5.00), pulmonologists at 4.93 (CI, 4.83-5.00), obstetricians at 4.74 (CI, 4.42-5.00), and nurses at 3.80 (CI, 3.06-4.54). A tailored approach to education is needed to ensure that healthcare professionals can communicate more effectively about RSV risks and vaccination benefits, fostering a proactive stance towards disease prevention and patient care. In essence, our study underscores the importance of knowledge in shaping a compassionate and responsive healthcare environment, ready to meet the challenges of RSV head-on.
将一种新疫苗引入免疫规划是全球抗击疫苗可预防疾病努力中的一项重大进展。世界卫生组织的数据表明,免疫接种每年可预防各种疾病导致的200万至300万人死亡,凸显了其在全球卫生领域的关键作用。本研究旨在评估希腊中部卫生专业人员对国家疫苗委员会可能出台的新型呼吸道合胞病毒(RSV)疫苗接种指南的知识、态度和预期接种行为。在邀请参与研究的450名卫生专业人员中,219人提供了回复,回复率约为55%。绝大多数(70.3%)准确识别了该疫苗目前的可获得性,62.1%知晓目前对孕妇接种RSV疫苗的建议。对于卫生专业人员是否支持在RSV疫苗上市并得到希腊国家免疫规划推荐时将其纳入国家疫苗接种计划,全科医生的支持度最高,平均得分为4.86(95%CI,4.69 - 5.00),其次是儿科医生,得分为4.76(95%CI,4.63 - 4.89),肺科医生为4.68(95%CI,4.36 - 5.00),产科医生为4.33(95%CI,3.95 - 4.71)。关于对疫苗接种的总体看法,除护士外,大多数卫生专业人员的意见高度一致。药剂师的认可度最高,得分为满分5分(CI,5.00 - 5.00),其次是儿科医生,得分为4.99(CI,4.97 - 5.00),全科医生为4.95(CI,4.85 - 5.00),肺科医生为4.93(CI,4.83 - 5.00),产科医生为4.74(CI,4.42 - 5.00),护士为3.80(CI,3.06 - 4.54)。需要采取针对性的教育方法,以确保医疗保健专业人员能够更有效地传达RSV风险和疫苗接种益处,培养对疾病预防和患者护理的积极态度。从本质上讲,我们的研究强调了知识在塑造一个富有同情心和响应能力的医疗环境中的重要性,随时准备正面应对RSV带来的挑战。